CD44 mediates hyaluronan to promote the differentiation of human amniotic mesenchymal stem cells into chondrocytes
Biotechnology Letters · 2023
DOI: 10.1007/s10529-022-03322-2 ↗Kurz gefasst
Fachartikel in der Zeitschrift Biotechnology Letters, 2023. Verfasst von Yan Xu und 2 weiteren Autor:innen. Beteiligte Einrichtung: Institute of Medicinal Biotechnology, Affiliated Hospital of Zunyi Medical University, 149 Dalian Road, Huichuan District, Zunyi, 563003, China. Hauptthemen laut MEDLINE: Chondrocytes, Mesenchymal Stem Cells. Die Arbeit wurde bisher 11-mal zitiert (Crossref) und nennt 40 Literaturangaben. Gefördert von: National Natural Science Foundation of China, Science and Technology Program of Guizhou Province, Guizhou High-Level Innovative Talent Support Program.
Abstract (Originalsprache)
OBJECTIVES: CD44 is the major receptor for hyaluronan (HA), but its effect on HA-induced differentiation of human amnion mesenchymal stem cells into chondrocytes is unclear. This study aimed to investigate the effects and mechanisms of CD44 in HA-induced chondrogenesis. METHODS: Immunocytochemistry and toluidine blue staining were used to assess the secretion of type II collagen and aggrecan, respectively. qRT-PCR and western blotting were performed to evaluate the expression of key genes and proteins. RESULTS: The expression of aggrecan and type II collagen was downregulated after using the anti-CD44 antibody (A3D8). The transcriptional levels of chondrocytes‑associated genes SRY‑box transcription factor 9, aggrecan, and collagen type II alpha 1 chain were also decreased. Thus, CD44 may mediate HA-induced differentiation of hAMSCs into chondrocytes. Further investigation indicated that expression of phosphorylated (p)‑Erk1/2 and p‑Smad2 decreased following CD44 inhibition. The changes in the expression of p-Erk1/2 and p-Smad2 were consistent after using the ERK1/2 inhibitor (U0126) and agonist (EGF), respectively. After administering the p-Smad2 inhibitor, the expression levels of p-ERK1/2 and p-Smad2 appeared downregulated. The results showed crosstalk between Erk1/2 and Smad2. Moreover, inhibition of p-Erk1/2 and p-Smad2 significantly reduced the accumulation of aggrecan and type II collagen. CONCLUSION: These data indicate that CD44 mediates HA-induced differentiation of hAMSCs into chondrocytes by regulating Erk1/2 and Smad2 signaling.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Institute of Medicinal Biotechnology, Affiliated Hospital of Zunyi Medical University, 149 Dalian Road, Huichuan District, Zunyi, 563003, China.
- Department of Orthopaedics, Affiliated Hospital of Zunyi Medical University, Zunyi, China.
- Institute of Medicinal Biotechnology, Affiliated Hospital of Zunyi Medical University, 149 Dalian Road, Huichuan District, Zunyi, 563003, China. 18300915601@126.com.
- Department of Orthopaedics, Affiliated Hospital of Zunyi Medical University, Zunyi, China. 18300915601@126.com.
Förderung
- National Natural Science Foundation of China
- Science and Technology Program of Guizhou Province
- Guizhou High-Level Innovative Talent Support Program
- Science and Technology Foundation of Zunyi Science and Technology Bureau
Zitieren
APA
Xu, Y., Wang, A. T., & Xiao, J. H. (2023). CD44 mediates hyaluronan to promote the differentiation of human amniotic mesenchymal stem cells into chondrocytes. Biotechnology Letters. https://doi.org/10.1007/s10529-022-03322-2
Vancouver
Xu Y, Wang AT, Xiao JH. CD44 mediates hyaluronan to promote the differentiation of human amniotic mesenchymal stem cells into chondrocytes. Biotechnology Letters. 2023. doi:10.1007/s10529-022-03322-2
BibTeX
@article{Xu2023,
author = {Xu, Yan and Wang, Ai-Tong and Xiao, Jian-Hui},
title = {CD44 mediates hyaluronan to promote the differentiation of human amniotic mesenchymal stem cells into chondrocytes},
journal = {Biotechnology Letters},
year = {2023},
doi = {10.1007/s10529-022-03322-2}
}
EUVIMED